test Browse by Author Names Browse by Titles of Works Browse by Subjects of Works Browse by Issue Dates of Works
       

Advanced Search
Home   
 
Browse   
Communities
& Collections
  
Issue Date   
Author   
Title   
Subject   
 
Sign on to:   
Receive email
updates
  
My Account
authorized users
  
Edit Profile   
 
Help   
About T-Space   

T-Space at The University of Toronto Libraries >
School of Graduate Studies - Theses >
Doctoral >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1807/26320

Title: Molecular Mechanisms of Intracellular Apolipoprotein B100 Degradation
Authors: Rutledge, Angela
Advisor: Adeli, Khosrow
Department: Laboratory Medicine and Pathobiology
Issue Date: 22-Feb-2011
Abstract: Apolipoprotein B100 (apoB), a necessary component of very low density lipoproteins, is overproduced in metabolic disorders such as type II diabetes, increasing the risk of atherosclerosis. ApoB production is regulated by intracellular degradation of the protein by proteasomes, ER-60-dependent degradation, or post-endoplasmic reticulum (ER) pre-secretory proteolysis (PERPP)/autophagy. The first aim of the present study was to understand how apoB is delivered from the ER to cytosolic proteasomes. We investigated the roles of cellular factors BiP, Derlin-1, VIMP, Hrd1, and p97 in targeting apoB to proteasomes. Co-immunoprecipitation experiments indicated that these factors associate with apoB. Use of dominant negative p97 adenoviruses led to ER accumulation of apoB, demonstrating that p97 is required to extract apoB from the ER. Therefore, these factors appear to be important for proteasomal degradation of apoB. ER-60, an ER protein with chaperone and cysteine protease activities, promotes apoB degradation through an unclear mechanism. To determine which property of ER-60 is involved, we used adenoviruses encoding wild-type ER-60 or a mutant form that lacked cysteine protease activity. Overexpression of wild-type, but not mutant, ER-60 induced apoB degradation, suggesting that ER-60 may function as a cysteine protease in apoB degradation. We then investigated post-translational degradation of apoB in cells undergoing ER stress induced by glucosamine treatment. Treatment of hepatocytes with glucosamine induced a significant loss of cellular apoB. We speculated that oxidative stress and subsequent degradation by PERPP might be responsible. Glucosamine treatment appeared to cause only a slight increase in oxidative stress, but treatment with the antioxidants desferrioxamine or vitamin E blocked glucosamine-induced apoB degradation, suggesting involvement of PERPP/autophagy. Overall, these studies have increased our understanding of the molecular mechanisms of intracellular apoB degradation and led to identification of critical factors and pathways that may be explored in the future to control hepatic apoB production in metabolic disease.
URI: http://hdl.handle.net/1807/26320
Appears in Collections:Doctoral

Files in This Item:

File Description SizeFormat
Rutledge_Angela_C_201011_PhD_thesis.pdf3.18 MBAdobe PDF
View/Open

This item is licensed under a Creative Commons License
Creative Commons

Items in T-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

uoft